Breaking Barriers: How Semaglutide Can Improve Health for Patients with Schizophrenia
A recent randomized clinical trial published in JAMA Psychiatry has shed new light on an important but often overlooked issue: the physical health of individuals living with schizophrenia (Ganeshalingam et al., 2025). While psychiatric treatment focuses on managing symptoms, many clients also face significant health risks related to weight gain, diabetes, and heart disease—much of it driven by the very medications that stabilize their mental health.